Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia

Hindlimb ischemia is an unmet medical need, especially for those patients unable to undergo vascular surgery. Cellular therapy, mainly through mesenchymal stromal cell (MSC) administration, may be a potentially attractive approach in this setting. In the current work, we aimed to assess the potentia...

Full description

Bibliographic Details
Main Authors: Arturo Ibáñez-Fonseca, Ana Rico, Silvia Preciado, Fernando González-Pérez, Sandra Muntión, Jesús García-Briñón, María-Carmen García-Macías, José Carlos Rodríguez-Cabello, Miguel Pericacho, Matilde Alonso, Fermín Sánchez-Guijo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.918602/full